7 reports

It offers products such as antirheumatic agent, antibacterial agent, antiviral agent and antifungal agents, among others.

  • Hepatitis
  • Renal Cancer
  • Japan
  • United States
  • Eisai Co., Ltd.

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Renal Cancer
  • United States
  • World
  • Company Sales
  • Product Initiative

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Oncology
  • Renal Cancer
  • United States
  • World
  • Product Initiative

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Lymphoma
  • Pharmaceutical
  • Renal Cancer
  • Therapy
  • Merck & Co., Inc.
  • PANCREATIC CANCER, GLIOBLASTOMA, RENAL CELL CARCINOMA AND OVARIAN CANCER.

DURVALUMAB ACTS AS CD## (PROGRAMMED CELL DEATH ##-LIGAND ## OR PDL-##) INHIBITOR.

  • Renal Cancer
  • Therapy
  • United States
  • Company
  • Product Initiative

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Cancer
  • Renal Cancer
  • Therapy
  • United States
  • Product Initiative

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Renal Cancer
  • United States
  • World
  • Company
  • Product Initiative